CN Stock MarketDetailed Quotes

600055 Beijing Wandong Medical Technology

Watchlist

14.39
+0.52+3.75%

Market Closed Nov 4 15:00 CST

10.12BMarket Cap54.92P/E (TTM)

Beijing Wandong Medical Technology Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

(Q9)Sep 30, 2022

(Q6)Jun 30, 2022

Assets

Current assets

Money funds

3.60%2.9B

10.91%3.02B

-0.76%3.03B

6.04%3.44B

15.44%2.8B

1.98%2.72B

0.88%3.06B

265.90%3.24B

268.57%2.43B

277.95%2.67B

Transactional financial assets

-7.87%466.19M

-42.38%325.78M

23.79%310M

-96.42%3.59M

-36.75%506.01M

5.91%565.42M

107.08%250.42M

-59.28%100.37M

81.83%800M

21.39%533.88M

Notes receivable and accounts receivable

25.90%392.57M

6.12%343.08M

-19.33%268.53M

-13.93%268.7M

27.46%311.82M

51.40%323.31M

72.00%332.89M

55.66%312.18M

73.23%244.64M

73.87%213.55M

-Notes receivable

523.62%5.75M

--2.91M

----

--921.33K

----

-Accounts receivable

24.42%386.82M

5.22%340.18M

-19.33%268.53M

-13.93%268.7M

27.09%310.9M

51.40%323.31M

72.00%332.89M

55.66%312.18M

73.33%244.64M

73.99%213.55M

Other receivables (including interest and dividends)

4.18%47.29M

27.50%41.58M

9.22%34.22M

6.05%24.66M

-6.80%45.39M

-19.68%32.61M

9.70%31.33M

-29.41%23.25M

62.41%48.71M

28.11%40.6M

-Other receivable

----

27.50%41.58M

----

-19.68%32.61M

----

-27.23%23.25M

----

32.22%40.6M

Contractual assets

314.27%1.41M

177.48%1.41M

74.55%1.15M

-54.34%339.38K

-60.82%506.68K

-52.90%656.67K

743.13%743.22K

1,367.07%1.29M

Advance payment

-20.28%65.28M

9.67%66.97M

-19.13%51.22M

-57.33%31.28M

6.69%81.88M

-1.22%61.06M

-2.11%63.33M

59.31%73.31M

163.92%76.75M

54.85%61.82M

Inventories

-17.66%281.14M

-11.69%308.8M

4.52%335.16M

41.70%377.8M

28.05%341.43M

44.89%349.69M

27.68%320.66M

38.65%266.62M

26.68%266.64M

-4.43%241.35M

Non-current assets due within one year

77.47%236.57M

49.60%241.02M

-5.11%202.31M

-10.07%221.04M

-9.18%133.3M

-13.93%161.11M

-3.19%213.21M

-3.13%245.78M

5.52%146.77M

6.23%187.18M

Other current assets

33.14%3.19M

-3.03%3.45M

849.90%37.48M

1,294.14%38.4M

26.96%2.4M

112.99%3.56M

-2.37%3.95M

64.52%2.75M

-28.84%1.89M

-33.63%1.67M

Total current assets

4.07%4.4B

3.12%4.35B

0.01%4.27B

3.22%4.4B

5.26%4.23B

6.80%4.22B

9.16%4.27B

129.26%4.27B

143.08%4.01B

122.93%3.95B

Non Current assets

Other non-current financial assets

11.28%344.78M

0.74%309.82M

-1.47%307.55M

21.96%307.55M

Investment real estate

-4.17%181.52M

-4.13%183.49M

-4.08%185.46M

-4.04%187.44M

-4.00%189.41M

-3.51%191.39M

-3.48%193.36M

-3.45%195.34M

-3.41%197.31M

-3.83%198.36M

Long-term equity investment

-13.71%15.12M

-7.33%16.29M

-7.68%16.43M

-9.15%16.4M

-5.10%17.53M

-4.50%17.58M

-2.79%17.8M

-1.07%18.05M

-0.25%18.47M

0.07%18.41M

Long term receivable account

-84.27%30.73M

-72.73%49.78M

-13.57%108.65M

-26.18%84.55M

-17.96%195.33M

-10.79%182.58M

-36.59%125.71M

-15.62%114.53M

-16.92%238.09M

-19.26%204.67M

Fixed assets

----

2.46%171.2M

----

1.19%167.08M

----

-2.16%170.85M

----

-3.48%165.12M

Constru in process

----

185.08%6.79M

----

--2.38M

----

--1.32M

----

Intangible assets

69.70%23.9M

-36.08%10.27M

-33.72%11.95M

-37.98%12.43M

-29.88%14.08M

-27.16%16.06M

-24.96%18.04M

-22.93%20.05M

-7.12%20.08M

-9.60%22.05M

Development expenditure

--13.99M

--14.66M

----

-80.29%5.7M

-79.62%5.7M

Long deferred expense

-3.18%17.76M

-12.50%16.77M

-11.95%17.61M

-18.23%17.56M

4.02%18.34M

4.06%19.16M

3.53%20M

4.57%21.47M

-14.37%17.63M

-13.55%18.42M

Deferred tax assets

-6.11%70.66M

-7.58%71.7M

-7.66%71.63M

20.88%75.26M

24.44%77.58M

9.89%62.26M

Usufruct assets

-27.58%11.45M

-26.31%12.34M

-25.14%13.22M

-25.70%14.11M

-28.59%15.81M

20.47%16.74M

14.81%17.66M

20.00%18.99M

1,174.65%22.14M

563.93%13.9M

Other non current assets

2.81%48.35M

0.20%48.35M

2.74%49.58M

1.92%47.03M

4.58%48.26M

34.31%46.14M

33.61%46.14M

Total non current assets

-10.89%936.68M

-9.54%945.37M

1.50%1.01B

-0.38%992.46M

-4.47%1.05B

-1.65%1.05B

-6.40%997.42M

-1.85%996.26M

-5.34%1.1B

-1.03%1.06B

Total assets

1.09%5.33B

0.61%5.29B

0.29%5.29B

2.54%5.4B

3.17%5.28B

5.01%5.26B

5.83%5.27B

82.98%5.26B

81.76%5.11B

76.15%5.01B

Liabilities

Current liabilities

Notes payable and accounts payable

-12.79%252.01M

-24.78%238.36M

-34.35%194.9M

-5.14%274.01M

8.97%288.96M

54.17%316.9M

45.20%296.87M

73.71%288.85M

51.78%265.18M

25.90%205.55M

-Notes payable

2.58%74.85M

-22.47%58.43M

-28.11%55.34M

131.25%71.35M

32.72%72.97M

132.32%75.36M

119.92%76.98M

-58.25%30.85M

-17.49%54.98M

-40.85%32.44M

-Accounts payable

-17.98%177.16M

-25.51%179.94M

-36.53%139.56M

-21.45%202.66M

2.76%216M

39.53%241.55M

29.77%219.89M

179.26%258M

94.49%210.2M

59.66%173.11M

Contract liabilities

-6.55%74.09M

-4.97%82.23M

25.50%101.52M

94.06%129.52M

44.26%79.28M

101.80%86.53M

62.95%80.89M

34.16%66.74M

-25.61%54.96M

-50.91%42.88M

Advance receipts

----

--125K

----

Salaries payable

22.73%40.2M

13.74%37.13M

17.36%35.81M

42.01%43.79M

4.86%32.75M

8.81%32.64M

9.78%30.51M

4.61%30.84M

7.26%31.24M

13.56%30M

Taxs payable

101.61%25.12M

229.15%19.59M

-57.24%2.84M

-69.21%10.47M

24.06%12.46M

15.80%5.95M

322.27%6.63M

55.89%34.02M

11.03%10.04M

-59.23%5.14M

Other payable (including interest and dividends)

-18.14%27.4M

2.85%29.68M

-21.12%21.22M

-8.32%27.07M

-1.10%33.47M

-52.87%28.86M

-15.29%26.91M

-5.60%29.53M

-12.46%33.84M

28.38%61.23M

-Dividend payable

----

--31.96M

-Other payable

----

2.85%29.68M

----

-1.41%28.86M

----

-5.60%29.53M

----

-38.63%29.27M

Non current liabilities due within one year

132.71%2.49M

181.63%4.01M

-6.86%4.35M

-14.86%5.33M

-61.90%1.07M

-60.19%1.42M

-37.61%4.67M

51.34%6.26M

--2.81M

3,348.64%3.57M

Other current liabilities

-28.61%12.87M

-28.88%15.36M

-7.25%22.24M

-1.03%35.35M

24.81%18.03M

55.69%21.6M

-1.04%23.98M

39.52%35.72M

93.50%14.44M

50.74%13.87M

Total current liabilities

-6.86%434.17M

-13.70%426.36M

-18.64%382.87M

6.80%525.54M

13.00%466.14M

36.38%494.03M

35.64%470.58M

49.86%492.08M

23.92%412.5M

4.50%362.24M

Current liabilities

Long term account payable

----

--353.61K

----

Long term salaries pay

4.29%17.95M

-0.58%17.21M

-6.59%17.31M

Deferred tax liabilities

-51.38%169.83K

-57.18%169.83K

50.04%349.3K

-56.74%396.62K

-57.60%232.8K

Long term deferred income

1.53%20.55M

-18.58%20.55M

-30.08%18.63M

-22.86%20.55M

-20.84%20.24M

-1.28%25.24M

4.20%26.64M

116.85%26.64M

93.83%25.56M

Lease liabilities

-28.27%11.19M

-27.22%11.4M

-28.58%11.19M

-28.97%15.6M

14.69%15.6M

11.37%15.66M

595.64%21.96M

254.35%13.6M

Total non current liabilities

-6.00%50.18M

-14.02%50.2M

-19.01%48.51M

-16.27%50.16M

-17.94%53.39M

2.98%58.39M

3.55%59.9M

34.40%59.9M

78.06%65.06M

57.05%56.7M

Total liabilities

-6.77%484.35M

-13.73%476.56M

-18.68%431.39M

4.30%575.7M

8.79%519.53M

31.86%552.42M

31.05%530.49M

48.01%551.98M

29.27%477.56M

9.46%418.94M

Shareholders equity

Paid-in capital

0.00%703.06M

30.00%703.06M

Other equity instruments

--2.78B

----

--2.78B

----

Capital reserve funds

----

0.01%2.78B

0.12%2.78B

----

0.44%2.78B

0.28%2.78B

214.17%2.78B

213.55%2.77B

Surplus reserve funds

8.01%225.22M

8.22%208.52M

12.87%192.67M

Retained profit

7.95%1.03B

9.77%1B

9.49%1.04B

9.50%1.01B

10.67%956.22M

11.20%912.08M

11.10%950.84M

10.73%920.4M

9.25%864M

-0.39%820.19M

Other composite income

-78.99%-3.06M

-65.15%-1.71M

30.51%-1.04M

Shareholders equity without minority interests

1.97%4.74B

2.28%4.71B

2.35%4.74B

2.30%4.71B

2.64%4.65B

2.66%4.6B

3.78%4.64B

92.21%4.61B

94.08%4.53B

89.55%4.48B

Minority interests

1.09%110.04M

2.89%109.91M

5.38%110.07M

3.74%109.15M

0.59%108.85M

-1.36%106.82M

-3.99%104.45M

-1.71%105.21M

-2.49%108.21M

12.14%108.29M

Total shareholder equity

1.95%4.85B

2.29%4.82B

2.42%4.85B

2.34%4.82B

2.59%4.76B

2.56%4.71B

3.60%4.74B

88.19%4.71B

89.69%4.64B

86.52%4.59B

Total liabilityies and equity

1.09%5.33B

0.61%5.29B

0.29%5.29B

2.54%5.4B

3.17%5.28B

5.01%5.26B

5.83%5.27B

82.98%5.26B

81.76%5.11B

76.15%5.01B

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Lixin Certified Public Accountants (Special General Partnership)

	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022	(Q9)Sep 30, 2022	(Q6)Jun 30, 2022
Assets
Current assets
Money funds	3.60%2.9B	10.91%3.02B	-0.76%3.03B	6.04%3.44B	15.44%2.8B	1.98%2.72B	0.88%3.06B	265.90%3.24B	268.57%2.43B	277.95%2.67B
Transactional financial assets	-7.87%466.19M	-42.38%325.78M	23.79%310M	-96.42%3.59M	-36.75%506.01M	5.91%565.42M	107.08%250.42M	-59.28%100.37M	81.83%800M	21.39%533.88M
Notes receivable and accounts receivable	25.90%392.57M	6.12%343.08M	-19.33%268.53M	-13.93%268.7M	27.46%311.82M	51.40%323.31M	72.00%332.89M	55.66%312.18M	73.23%244.64M	73.87%213.55M
-Notes receivable	523.62%5.75M	--2.91M	----	----	--921.33K	----	----	----	----	----
-Accounts receivable	24.42%386.82M	5.22%340.18M	-19.33%268.53M	-13.93%268.7M	27.09%310.9M	51.40%323.31M	72.00%332.89M	55.66%312.18M	73.33%244.64M	73.99%213.55M
Other receivables (including interest and dividends)	4.18%47.29M	27.50%41.58M	9.22%34.22M	6.05%24.66M	-6.80%45.39M	-19.68%32.61M	9.70%31.33M	-29.41%23.25M	62.41%48.71M	28.11%40.6M
-Other receivable	----	27.50%41.58M	----	----	----	-19.68%32.61M	----	-27.23%23.25M	----	32.22%40.6M
Contractual assets	314.27%1.41M	177.48%1.41M	74.55%1.15M	74.55%1.15M	-54.34%339.38K	-60.82%506.68K	-52.90%656.67K	-52.90%656.67K	743.13%743.22K	1,367.07%1.29M
Advance payment	-20.28%65.28M	9.67%66.97M	-19.13%51.22M	-57.33%31.28M	6.69%81.88M	-1.22%61.06M	-2.11%63.33M	59.31%73.31M	163.92%76.75M	54.85%61.82M
Inventories	-17.66%281.14M	-11.69%308.8M	4.52%335.16M	41.70%377.8M	28.05%341.43M	44.89%349.69M	27.68%320.66M	38.65%266.62M	26.68%266.64M	-4.43%241.35M
Non-current assets due within one year	77.47%236.57M	49.60%241.02M	-5.11%202.31M	-10.07%221.04M	-9.18%133.3M	-13.93%161.11M	-3.19%213.21M	-3.13%245.78M	5.52%146.77M	6.23%187.18M
Other current assets	33.14%3.19M	-3.03%3.45M	849.90%37.48M	1,294.14%38.4M	26.96%2.4M	112.99%3.56M	-2.37%3.95M	64.52%2.75M	-28.84%1.89M	-33.63%1.67M
Total current assets	4.07%4.4B	3.12%4.35B	0.01%4.27B	3.22%4.4B	5.26%4.23B	6.80%4.22B	9.16%4.27B	129.26%4.27B	143.08%4.01B	122.93%3.95B
Non Current assets
Other non-current financial assets	11.28%344.78M	11.28%344.78M	11.28%344.78M	11.28%344.78M	0.74%309.82M	0.74%309.82M	0.74%309.82M	0.74%309.82M	-1.47%307.55M	21.96%307.55M
Investment real estate	-4.17%181.52M	-4.13%183.49M	-4.08%185.46M	-4.04%187.44M	-4.00%189.41M	-3.51%191.39M	-3.48%193.36M	-3.45%195.34M	-3.41%197.31M	-3.83%198.36M
Long-term equity investment	-13.71%15.12M	-7.33%16.29M	-7.68%16.43M	-9.15%16.4M	-5.10%17.53M	-4.50%17.58M	-2.79%17.8M	-1.07%18.05M	-0.25%18.47M	0.07%18.41M
Long term receivable account	-84.27%30.73M	-72.73%49.78M	-13.57%108.65M	-26.18%84.55M	-17.96%195.33M	-10.79%182.58M	-36.59%125.71M	-15.62%114.53M	-16.92%238.09M	-19.26%204.67M
Fixed assets	----	2.46%171.2M	----	----	----	1.19%167.08M	----	-2.16%170.85M	----	-3.48%165.12M
Constru in process	----	185.08%6.79M	----	----	----	--2.38M	----	--1.32M	----	----
Intangible assets	69.70%23.9M	-36.08%10.27M	-33.72%11.95M	-37.98%12.43M	-29.88%14.08M	-27.16%16.06M	-24.96%18.04M	-22.93%20.05M	-7.12%20.08M	-9.60%22.05M
Development expenditure	--13.99M	--14.66M	--14.66M	--14.66M	----	----	----	----	-80.29%5.7M	-79.62%5.7M
Long deferred expense	-3.18%17.76M	-12.50%16.77M	-11.95%17.61M	-18.23%17.56M	4.02%18.34M	4.06%19.16M	3.53%20M	4.57%21.47M	-14.37%17.63M	-13.55%18.42M
Deferred tax assets	-6.11%70.66M	-6.11%70.66M	-7.58%71.7M	-7.66%71.63M	20.88%75.26M	20.88%75.26M	24.44%77.58M	24.44%77.58M	9.89%62.26M	9.89%62.26M
Usufruct assets	-27.58%11.45M	-26.31%12.34M	-25.14%13.22M	-25.70%14.11M	-28.59%15.81M	20.47%16.74M	14.81%17.66M	20.00%18.99M	1,174.65%22.14M	563.93%13.9M
Other non current assets	2.81%48.35M	2.81%48.35M	0.20%48.35M	2.74%49.58M	1.92%47.03M	1.92%47.03M	4.58%48.26M	4.58%48.26M	34.31%46.14M	33.61%46.14M
Total non current assets	-10.89%936.68M	-9.54%945.37M	1.50%1.01B	-0.38%992.46M	-4.47%1.05B	-1.65%1.05B	-6.40%997.42M	-1.85%996.26M	-5.34%1.1B	-1.03%1.06B
Total assets	1.09%5.33B	0.61%5.29B	0.29%5.29B	2.54%5.4B	3.17%5.28B	5.01%5.26B	5.83%5.27B	82.98%5.26B	81.76%5.11B	76.15%5.01B
Liabilities
Current liabilities
Notes payable and accounts payable	-12.79%252.01M	-24.78%238.36M	-34.35%194.9M	-5.14%274.01M	8.97%288.96M	54.17%316.9M	45.20%296.87M	73.71%288.85M	51.78%265.18M	25.90%205.55M
-Notes payable	2.58%74.85M	-22.47%58.43M	-28.11%55.34M	131.25%71.35M	32.72%72.97M	132.32%75.36M	119.92%76.98M	-58.25%30.85M	-17.49%54.98M	-40.85%32.44M
-Accounts payable	-17.98%177.16M	-25.51%179.94M	-36.53%139.56M	-21.45%202.66M	2.76%216M	39.53%241.55M	29.77%219.89M	179.26%258M	94.49%210.2M	59.66%173.11M
Contract liabilities	-6.55%74.09M	-4.97%82.23M	25.50%101.52M	94.06%129.52M	44.26%79.28M	101.80%86.53M	62.95%80.89M	34.16%66.74M	-25.61%54.96M	-50.91%42.88M
Advance receipts	----	----	----	----	--125K	--125K	--125K	--125K	----	----
Salaries payable	22.73%40.2M	13.74%37.13M	17.36%35.81M	42.01%43.79M	4.86%32.75M	8.81%32.64M	9.78%30.51M	4.61%30.84M	7.26%31.24M	13.56%30M
Taxs payable	101.61%25.12M	229.15%19.59M	-57.24%2.84M	-69.21%10.47M	24.06%12.46M	15.80%5.95M	322.27%6.63M	55.89%34.02M	11.03%10.04M	-59.23%5.14M
Other payable (including interest and dividends)	-18.14%27.4M	2.85%29.68M	-21.12%21.22M	-8.32%27.07M	-1.10%33.47M	-52.87%28.86M	-15.29%26.91M	-5.60%29.53M	-12.46%33.84M	28.38%61.23M
-Dividend payable	----	----	----	----	----	----	----	----	----	--31.96M
-Other payable	----	2.85%29.68M	----	----	----	-1.41%28.86M	----	-5.60%29.53M	----	-38.63%29.27M
Non current liabilities due within one year	132.71%2.49M	181.63%4.01M	-6.86%4.35M	-14.86%5.33M	-61.90%1.07M	-60.19%1.42M	-37.61%4.67M	51.34%6.26M	--2.81M	3,348.64%3.57M
Other current liabilities	-28.61%12.87M	-28.88%15.36M	-7.25%22.24M	-1.03%35.35M	24.81%18.03M	55.69%21.6M	-1.04%23.98M	39.52%35.72M	93.50%14.44M	50.74%13.87M
Total current liabilities	-6.86%434.17M	-13.70%426.36M	-18.64%382.87M	6.80%525.54M	13.00%466.14M	36.38%494.03M	35.64%470.58M	49.86%492.08M	23.92%412.5M	4.50%362.24M
Current liabilities
Long term account payable	----	--353.61K	----	----	----	----	----	----	----	----
Long term salaries pay	4.29%17.95M	4.29%17.95M	4.29%17.95M	4.29%17.95M	-0.58%17.21M	-0.58%17.21M	-0.58%17.21M	-0.58%17.21M	-6.59%17.31M	-6.59%17.31M
Deferred tax liabilities	-51.38%169.83K	-51.38%169.83K	-57.18%169.83K	-57.18%169.83K	50.04%349.3K	50.04%349.3K	-56.74%396.62K	-56.74%396.62K	-57.60%232.8K	-57.60%232.8K
Long term deferred income	1.53%20.55M	-18.58%20.55M	-30.08%18.63M	-22.86%20.55M	-20.84%20.24M	-1.28%25.24M	4.20%26.64M	116.85%26.64M	93.83%25.56M	93.83%25.56M
Lease liabilities	-28.27%11.19M	-28.27%11.19M	-27.22%11.4M	-28.58%11.19M	-28.97%15.6M	14.69%15.6M	11.37%15.66M	11.37%15.66M	595.64%21.96M	254.35%13.6M
Total non current liabilities	-6.00%50.18M	-14.02%50.2M	-19.01%48.51M	-16.27%50.16M	-17.94%53.39M	2.98%58.39M	3.55%59.9M	34.40%59.9M	78.06%65.06M	57.05%56.7M
Total liabilities	-6.77%484.35M	-13.73%476.56M	-18.68%431.39M	4.30%575.7M	8.79%519.53M	31.86%552.42M	31.05%530.49M	48.01%551.98M	29.27%477.56M	9.46%418.94M
Shareholders equity
Paid-in capital	0.00%703.06M	0.00%703.06M	0.00%703.06M	0.00%703.06M	0.00%703.06M	0.00%703.06M	0.00%703.06M	30.00%703.06M	30.00%703.06M	30.00%703.06M
Other equity instruments	--2.78B	----	----	--2.78B	----	----	----	----	----	----
Capital reserve funds	----	0.01%2.78B	0.12%2.78B	----	0.44%2.78B	0.44%2.78B	0.28%2.78B	214.17%2.78B	213.55%2.77B	213.55%2.77B
Surplus reserve funds	8.01%225.22M	8.01%225.22M	8.01%225.22M	8.01%225.22M	8.22%208.52M	8.22%208.52M	8.22%208.52M	8.22%208.52M	12.87%192.67M	12.87%192.67M
Retained profit	7.95%1.03B	9.77%1B	9.49%1.04B	9.50%1.01B	10.67%956.22M	11.20%912.08M	11.10%950.84M	10.73%920.4M	9.25%864M	-0.39%820.19M
Other composite income	-78.99%-3.06M	-78.99%-3.06M	-78.99%-3.06M	-78.99%-3.06M	-65.15%-1.71M	-65.15%-1.71M	-65.15%-1.71M	-65.15%-1.71M	30.51%-1.04M	30.51%-1.04M
Shareholders equity without minority interests	1.97%4.74B	2.28%4.71B	2.35%4.74B	2.30%4.71B	2.64%4.65B	2.66%4.6B	3.78%4.64B	92.21%4.61B	94.08%4.53B	89.55%4.48B
Minority interests	1.09%110.04M	2.89%109.91M	5.38%110.07M	3.74%109.15M	0.59%108.85M	-1.36%106.82M	-3.99%104.45M	-1.71%105.21M	-2.49%108.21M	12.14%108.29M
Total shareholder equity	1.95%4.85B	2.29%4.82B	2.42%4.85B	2.34%4.82B	2.59%4.76B	2.56%4.71B	3.60%4.74B	88.19%4.71B	89.69%4.64B	86.52%4.59B
Total liabilityies and equity	1.09%5.33B	0.61%5.29B	0.29%5.29B	2.54%5.4B	3.17%5.28B	5.01%5.26B	5.83%5.27B	82.98%5.26B	81.76%5.11B	76.15%5.01B
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	--	--	Unqualified opinion	--	--	--	Unqualified opinion	--	--
Auditor	--	--	--	Lixin Certified Public Accountants (Special General Partnership)	--	--	--	Lixin Certified Public Accountants (Special General Partnership)	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

600055 Beijing Wandong Medical Technology

Beijing Wandong Medical Technology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Analysis

Analyst Rating

Price Target